Subscribe to Newsletter
Subspecialties Retina

Targeting CSCR with Navigated Laser

sponsored by OD-OS

Watch here

Clinical results from around the world provide evidence on the effectiveness of navigated retinal laser therapy.1

Navigation is especially beneficial for the treatment of Central Serous Chorioretinopathy (CSCR) as it helps precisely target the leakage point - with threshold laser for extrafoveal burns as well as microsecond pulsing laser for subfoveal treatment.

This webinar aims at educating physicians about recent study results and modern treatment with precise photocoagulation and tissue-friendly subthreshold laser. Dr. Brown and his team were among the first users of the Navilas 577s navigated retina laser and have used the system for their daily work and in long-term clinical trials.

1 www.od-os.com/publications

Learning Objectives of Webinar:

  1. Current treatment paradigms and evidence on the effectiveness of laser treatment for CSCR
  2. Principles of navigated laser including the ability to check treatment progress based on the digital documentation.
  3. Microsecond pulse treatment options as a tissue-friendly alternative

Visit our Webinar Hub

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: